Cargando…
Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
OBJECTIVE: Circulating tumour DNA (ctDNA) sequencing is increasingly used in the clinical management of patients with colorectal cancer. However, the genomic heterogeneity in ctDNA during treatments and its impact on clinical outcomes remain largely unknown. DESIGN: We conducted a prospective cohort...
Autores principales: | Wang, Feng, Huang, You-Sheng, Wu, Hao-Xiang, Wang, Zi-Xian, Jin, Ying, Yao, Yi-Chen, Chen, Yan-Xing, Zhao, Qi, Chen, Shifu, He, Ming-Ming, Luo, Hui-Yan, Qiu, Miao-Zhen, Wang, De-shen, Wang, Feng-Hua, Xu, Mingyan, Li, Yu-Hong, Xu, Rui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185813/ https://www.ncbi.nlm.nih.gov/pubmed/34489309 http://dx.doi.org/10.1136/gutjnl-2021-324852 |
Ejemplares similares
-
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study
por: Khan, Khurum, et al.
Publicado: (2018) -
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
por: Peng, Szu-Min, et al.
Publicado: (2021) -
Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
por: Chiu, Han-Mo, et al.
Publicado: (2021) -
Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer
por: Xu, Lixia, et al.
Publicado: (2016) -
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer
por: Sun, Lei, et al.
Publicado: (2021)